What's in Washington Homeopathic Products's pipeline?

Washington Homeopathic Products has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Washington Homeopathic Products's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/washington-homeopathic-products.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Washington Homeopathic Products — Portfolio Competitive Intelligence Brief

Washington Homeopathic Products pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Antimonium Crudum Kit Refill	ANTIMONY	marketed			Immunology
Thiosinaminum	ALLYLTHIOUREA	marketed			Dermatology

Therapeutic area mix

Dermatology · 1
Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Washington Homeopathic Products:

Cite this brief

Drug Landscape (2026). Washington Homeopathic Products — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/washington-homeopathic-products. Accessed 2026-05-16.